Intertek, the FTSE 100 giant specializing in quality assurance and product testing, has rejected a sweetened takeover bid from the Swedish private equity firm EQT. The offer, valued at approximately $12.1 billion (roughly £10 billion), represented a significant increase over previous approaches but failed to convince Intertek’s board that the price sufficiently reflected the company’s long-term value.
The rejection marks a pivotal moment in a high-stakes game of valuation. For EQT, one of Europe’s most aggressive private equity players, Intertek represents a crown jewel in the Testing, Inspection, and Certification (TIC) sector—a business model prized for its recurring revenue and resilience during economic downturns. For Intertek, the decision to walk away from a multi-billion dollar cash offer suggests a deep confidence in its independent growth trajectory and a belief that the market is still underpricing its global footprint.
This standoff comes at a time when the UK market is increasingly viewed as a hunting ground for private equity. With many FTSE companies trading at discounts compared to their US peers, firms like EQT are stepping in with “fat premiums” to take public companies private. However, as this latest clash proves, a premium is only attractive if it meets the board’s internal threshold for “fair value.”
The Valuation Gap: From £8.9 Billion to £10 Billion
The path to this rejection was not a single event but a progression of attempts by EQT to find Intertek’s price. Earlier reports indicated a lower initial approach in the neighborhood of £8.9 billion, which was dismissed. The subsequent jump to the $12.1 billion (£10 billion) mark was an attempt to bridge that gap, offering shareholders a significant windfall in cash.
In the world of corporate finance, the jump from £8.9 billion to £10 billion is more than just a numerical increase; it is a signal of intent. It shows that EQT is willing to pay a substantial premium to secure the asset. Yet, the board’s rejection indicates that the “sweetened” offer still didn’t reach the “knockout” price required to force a sale. When a board rejects a bid of this size, it usually means they believe the company’s future cash flows—driven by tightening global regulations and a surge in sustainability certifications—will eventually yield a higher valuation for shareholders.
| Bid Stage | Estimated Value | Outcome | Key Driver |
|---|---|---|---|
| Initial Approach | ~£8.9 Billion | Rejected | Undervaluation of core assets |
| Sweetened Offer | ~$12.1 Billion (£10bn) | Rejected | Insufficient premium for long-term growth |
| Current Status | N/A | Independent | Board maintains strategic autonomy |
Why Private Equity Wants the TIC Sector
To understand why EQT is pursuing Intertek so doggedly, one has to look at the nature of the Testing, Inspection, and Certification (TIC) industry. Unlike traditional manufacturing or retail, TIC services are often mandated by law or industry standards. Whether it is ensuring a toy is lead-free, a bridge is structurally sound, or a carbon emission report is accurate, these services are non-discretionary.
For a private equity firm, this creates a “defensive” asset. When the broader economy wobbles, companies may cut their marketing budgets, but they cannot stop certifying their products for export or complying with safety regulations. This stability allows PE firms to apply leverage to the acquisition, optimize operational efficiencies, and eventually exit at a higher multiple once the company has expanded its service offerings.
EQT’s interest is part of a broader trend of “take-privates” in the UK. The current macroeconomic environment—characterized by fluctuating interest rates and a perceived lack of appetite from domestic public investors—has left many high-quality UK firms undervalued. EQT is betting that by taking Intertek private, they can accelerate growth away from the quarterly scrutiny of public markets.
The Legal and Strategic Chessboard
A deal of this magnitude requires an army of advisors. Reports indicate that top-tier legal firms, including Freshfields and Slaughter and May, have been involved in the advisory process as EQT tabled its improved bid. The involvement of these firms underscores the complexity of the transaction, which involves navigating UK takeover codes and managing the expectations of a diverse institutional shareholder base.
The strategic tension now lies between the board and the shareholders. While the board has a fiduciary duty to act in the best interest of the company, institutional investors—such as pension funds and asset managers—often find it demanding to ignore a cash bid at a steep premium. If EQT decides to return with an even higher offer, or if they attempt a hostile bid by appealing directly to shareholders, the board will face increasing pressure to justify why staying public is the superior option.
Currently, the known constraints are clear: EQT has shown its hand by increasing the bid, and Intertek has set a high bar by rejecting it. The unknown is whether EQT has the appetite to push the price toward a level that the board cannot reasonably refuse, or if they will pivot their capital toward other undervalued targets in the FTSE.
Disclaimer: This article is for informational purposes only and does not constitute financial, legal, or investment advice.
The next critical checkpoint will be Intertek’s upcoming regulatory filings and shareholder communications, where the board may provide further guidance on its valuation targets. Market participants will also be watching for any formal announcement from EQT regarding a revised offer or a withdrawal from the process.
What do you think about the current wave of private equity takeovers in the UK? Let us know in the comments or share this story with your network.
